Compare PRCH & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | STAA |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2019 | 1995 |
| Metric | PRCH | STAA |
|---|---|---|
| Price | $17.06 | $23.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $18.63 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.8M | 983.4K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | N/A |
| EPS | 0.01 | ★ 0.26 |
| Revenue | ★ $482,414,000.00 | $239,442,000.00 |
| Revenue This Year | $4.15 | $30.82 |
| Revenue Next Year | $17.05 | $8.41 |
| P/E Ratio | $1,709.00 | ★ $89.00 |
| Revenue Growth | ★ 10.18 | N/A |
| 52 Week Low | $6.36 | $15.59 |
| 52 Week High | $19.44 | $35.87 |
| Indicator | PRCH | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 65.65 | 42.21 |
| Support Level | $9.08 | $22.10 |
| Resistance Level | N/A | $25.54 |
| Average True Range (ATR) | 0.73 | 1.33 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 83.97 | 31.03 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.